Resources

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003900/

Learn more
S100A6 Promotes B Lymphocyte Penetration Through the Blood-Brain Barrier in Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901080/

Learn more
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535747/

Learn more
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531245/

Learn more
Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444136/

Learn more
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537134/

Learn more
Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398345/

Learn more
Editorial: Recent Advances in Psychiatry From Psycho-Neuro-Immunology Research: Autoimmune Encephalitis, Autoimmune Encephalopathy, and Mild Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455066/

Learn more
Autoimmune seizures and epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391086/

Learn more
The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536844/

Learn more